Document Detail


Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
MedLine Citation:
PMID:  17405779     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: To test four 16-membered macrolides (josamycin, spiramycin, midecamycin and rokitamycin) along with other compounds in the same class (erythromycin, clarithromycin, roxithromycin and azithromycin) plus clindamycin and telithromycin, against Streptococcus pyogenes and Streptococcus pneumoniae isolates with well-characterized resistance genotypes. METHODS: Four hundred and eighty-six isolates of S. pyogenes and 375 isolates of S. pneumoniae were assayed for their macrolide susceptibilities and investigated by PCR to detect their different erythromycin resistance genes. All strains had been isolated over the period 2002-2003 from specimens of different human origin obtained in 14 different Italian centres. RESULTS: All 16-membered macrolides showed very low MICs (MIC(50)s and MIC(90)s, < or =0.06-0.5 mg/L) for the erythromycin-susceptible isolates and for those with the M phenotype, but the telithromycin MICs for the M-type isolates were at least four times higher (MIC(90)s, 0.5 mg/L). In S. pyogenes, the MIC(50)s of 16-membered macrolides for the cMLS(B) isolates were > or = 256 mg/L, whereas that for telithromycin was 4 mg/L; the MIC(50)s of 16-membered macrolides and telithromycin ranged from < or = 0.06 to 0.5 mg/L for the iMLS(B) isolates with erm(A) and from 0.12 to > or = 256 mg/L for those with erm(B). In S. pneumoniae, the MIC(50)s of the 16-membered macrolides for the cMLS(B) isolates ranged from 0.5 to 128 mg/L, whereas for the iMLS(B) isolates their values ranged from < or = 0.06 to 4 mg/L; the MIC(50)s and MIC(90)s of telithromycin for both the cMLS(B) and the iMLS(B) isolates ranged from < or = 0.06 to 0.12 mg/L. CONCLUSIONS: MICs ranged for all the drugs, except telithromycin, from < or = 0.06 to > or = 256 mg/L, with 15% to 30% resistant S. pyogenes for all drugs tested except clindamycin (8%) and telithromycin (5.4%) and 10% to 40% resistant S. pneumoniae for all drugs tested except telithromycin (0.3%). In both S. pyogenes and S. pneumoniae, erythromycin resistance related to a mef gene meant that telithromycin MICs were definitely higher than in erythromycin-susceptible isolates, although telithromycin susceptibility was preserved in all cases. In S. pyogenes, the activity of both 16-membered macrolides and telithromycin against the iMLS(B) strains proved to be dependent on the erm gene involved, being greater against isolates with erm(A).
Authors:
Annarita Mazzariol; Raffaella Koncan; Luca Agostino Vitali; Giuseppe Cornaglia
Related Documents :
8971709 - Molecular cloning and functional analysis of a novel macrolide-resistance determinant, ...
12604549 - Erythromycin and clindamycin resistance and telithromycin susceptibility in streptococc...
3530749 - In vitro killing of erythromycin-exposed group a streptococci by polymorphonuclear leuk...
12562699 - Significant increase in the prevalence of erythromycin-resistant, clindamycin- and mioc...
15223559 - Presence and mechanism of macrolide-lincosamide resistance in enterococcus columbae str...
9436959 - Macrolides are ideal for empiric therapy of community-acquired pneumonia in the immunoc...
18611589 - Pneumococcal resistance to the third-generation cephalosporins: clinical, laboratory an...
6802799 - L-serine degradation in escherichia coli k-12: directly isolated ssd mutants and their ...
20929539 - Simultaneous detection and differentiation by multiplex real time rt-pcr of highly path...
Publication Detail:
Type:  Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't     Date:  2007-04-03
Journal Detail:
Title:  The Journal of antimicrobial chemotherapy     Volume:  59     ISSN:  0305-7453     ISO Abbreviation:  J. Antimicrob. Chemother.     Publication Date:  2007 Jun 
Date Detail:
Created Date:  2007-05-17     Completed Date:  2007-08-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7513617     Medline TA:  J Antimicrob Chemother     Country:  England    
Other Details:
Languages:  eng     Pagination:  1171-6     Citation Subset:  IM    
Affiliation:
Dipartimento di Patologia, Sezione di Microbiologia, Università degli Studi di Verona, Strada Le Grazie 8, Verona, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Bacterial Agents / pharmacology*
Drug Resistance, Bacterial
Erythromycin / pharmacology*
Genotype
Humans
Italy / epidemiology
Ketolides / pharmacology*
Macrolides / pharmacology*
Microbial Sensitivity Tests
Pneumococcal Infections / epidemiology,  microbiology
Reverse Transcriptase Polymerase Chain Reaction
Streptococcal Infections / epidemiology,  microbiology
Streptococcus pneumoniae / drug effects*
Streptococcus pyogenes / drug effects*
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Ketolides; 0/Macrolides; 0/telithromycin; 114-07-8/Erythromycin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Physicians' experiences using commercial e-prescribing systems.
Next Document:  Evaluation of the in vivo efficacy of topical tobramycin against Pseudomonas sinonasal biofilms.